-
Barteling S J, Vreeswijk J. Developments in foot-and-mouth disease vaccines[J]. Vaccine, 1991, 9(2): 75-88. doi: 10.1016/0264-410X(91)90261-4
-
Beck E, Strohmaier K. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination[J]. J Virol, 1987, 61(): 1621-1629.
-
Blanco E, Garcia-Briones M, Sanz-Parra A. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus[J]. J Virol, 2001, 75(7): 3164-3174. doi: 10.1128/JVI.75.7.3164-3174.2001
-
Brumeanu T D, Casares S, Dehazya P. Presentation of a viral peptide assembled on the carbohydrate moieties of immunoglobulin does not require processing[J]. Eur J Immunol, 1997, 27(9): 2408-2416. doi: 10.1002/(ISSN)1521-4141
-
Brumeanu T D, Swiggard W J, Steinman R M. Efficient loading of identical viral peptide onto class Ⅱ molecules by antigenized immunoglobulin and influenza virus[J]. J Exp Med, 1993, 178(5): 1795-1799. doi: 10.1084/jem.178.5.1795
-
Cedillo-Barrón L, Foster-Cuevas M, Belsham G J. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase[J]. J Gen Virol, 2001, 82(): 1713-1724. doi: 10.1099/0022-1317-82-7-1713
-
Chan E W C, Wong S C S, Cheng W Y. An immunoglobulin G based chimeric protein induced foot-and-mouth disease specific immune response in swine[J]. Vaccine, 2001, 19(): 538-546.
-
Collen T, Dimmarchi R, Doel T R. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle[J]. J Immunol, 1991, 146(): 749-755.
-
Doel T R. Natural and vaccine induced immunity to FMD[J]. Curr Top Microbiol Immunol, 2005, 288(): 103-131.
-
Doel T R. FMD vaccines[J]. Virus Res, 2003, 91(): 81-99. doi: 10.1016/S0168-1702(02)00261-7
-
Gerner W, Hammer S E, Wiesmüller K H. Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes[J]. J Virol, 2009, 83(): 4039-4050. doi: 10.1128/JVI.01534-08
-
Golde W T, Pacheco J M, Duque H. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response[J]. Vaccine, 2005, 23(): 5775-5782. doi: 10.1016/j.vaccine.2005.07.043
-
Grubman M J, Baxt B. Foot and mouth disease[J]. Clin Microbiol Rev, 2004, 17(2): 465-493. doi: 10.1128/CMR.17.2.465-493.2004
-
He C, Wang H, Wei H. A recombinant truncated FMDV 3AB protein used to better distinguish between infected and vaccinated cattle[J]. Vaccine, 2010, 28(19): 3435-2439. doi: 10.1016/j.vaccine.2010.02.072
-
Kadkhodayan S, Knapp M S, Schmidt J J. Cloning, Expression, and One-Step Purification of the Minimal Essential Domain of the Light Chain of Botulinum Neurotoxin Type A[J]. Protein Expr Purif, 2000, 19(): 125-130. doi: 10.1006/prep.2000.1227
-
Mackay D K, Forsyth M A, Davies P R. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, nonstructural proteins in ELISA[J]. Vaccine, 1998, 16(5): 446-459. doi: 10.1016/S0264-410X(97)00227-2
-
Rodriguez L L, Barrera J, Kramer E. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type O VP1 and a promiscuous T-helper epitope induces eptide-specific antibodies but fails to protect cattle against viral challenge[J]. Vaccine, 2003, 21(): 3751-3756. doi: 10.1016/S0264-410X(03)00364-5
-
Rodriguez L L, Grubman M. Foot and mouth disease virus vaccines[J]. Vaccine, 2009, 27(): D90-D94. doi: 10.1016/j.vaccine.2009.08.039
-
Shao J J, Wong C K, Lin T. Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine[J]. Clin Vaccine Immunol, 2011, 18(1): 143-149. doi: 10.1128/CVI.00236-10
-
Su C X, Duan X G, Wang X Q. Heterologous of FMDV immunodominant epitopes and HSP70 in P[J]. pastoris and the subesequent immune response in mice. Vet Mirobiol, 2007, 124(): 256-263.
-
Sutmoller P, Barteling S S, Olascoaga R C. Control and eradication of foot-and-mouth disease[J]. Virus Res, 2003, 91(1): 101-144. doi: 10.1016/S0168-1702(02)00262-9
-
Taboga O, Tami C, Carrillo E. A largescale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants[J]. J Virol, 1997, 71(): 2606-2614.
-
van Lierop M J, Wagenaar J P, van Noort J M. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus[J]. J Virol, 1995, 69(): 4511-4514.
-
Yi J Z, Liu M Q, Zhu C Z. Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pig[J]. Acta Biochim Biophys Sin (Shanghai), 2004, 36(9): 589-596. doi: 10.1093/abbs/36.9.589
-
Zaghouani H, Steinman R, Nonacs R. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule[J]. Science, 1993, 259(): 224-227. doi: 10.1126/science.7678469